Adaptive Biotechnologies Reports Second Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Adaptive Biotechnologies (ADPT) Tops Q2 EPS by 7c
August 4, 2021 5:07 PM EDTAdaptive Biotechnologies (NASDAQ: ADPT) reported Q2 EPS of ($0.35), $0.07 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $38.5 million versus the consensus estimate of $31.26 million.
GUIDANCE:
Adaptive Biotechnologies sees FY2021 revenue of $148-155 million, versus the consensus of... More
